Reports Q1 revenue $420.4M, consensus $409.35M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NBIX:
- Neurocrine Biosciences Reports First Quarter 2023 Financial Results
- JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
- Neurocrine price target raised to $110 from $108 at RBC Capital
- Neurocrine price target lowered to $127 from $131 at Citi
- Neurocrine price target lowered to $125 from $137 at UBS